Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

6KX2

Crystal structure of GDP bound RhoA protein

Summary for 6KX2
Entry DOI10.2210/pdb6kx2/pdb
DescriptorTransforming protein RhoA, GUANOSINE-5'-DIPHOSPHATE (3 entities in total)
Functional Keywordsrhoa, gdp, complex, cell invasion
Biological sourceHomo sapiens (Human)
Total number of polymer chains1
Total formula weight20884.53
Authors
Zhang, H.,Luo, C. (deposition date: 2019-09-09, release date: 2020-08-19, Last modification date: 2023-11-22)
Primary citationSun, Z.,Zhang, H.,Zhang, Y.,Liao, L.,Zhou, W.,Zhang, F.,Lian, F.,Huang, J.,Xu, P.,Zhang, R.,Lu, W.,Zhu, M.,Tao, H.,Yang, F.,Ding, H.,Chen, S.,Yue, L.,Zhou, B.,Zhang, N.,Tan, M.,Jiang, H.,Chen, K.,Liu, B.,Liu, C.,Dang, Y.,Luo, C.
Covalent Inhibitors Allosterically Block the Activation of Rho Family Proteins and Suppress Cancer Cell Invasion.
Adv Sci, 7:2000098-2000098, 2020
Cited by
PubMed Abstract: The Rho family GTPases are crucial drivers of tumor growth and metastasis. However, it is difficult to develop GTPases inhibitors due to a lack of well-characterized binding pockets for compounds. Here, through molecular dynamics simulation of the RhoA protein, a groove around cysteine 107 (Cys107) that is relatively well-conserved within the Rho family is discovered. Using a combined strategy, the novel inhibitor DC-Rhoin is discovered, which disrupts interaction of Rho proteins with guanine nucleotide exchange factors (GEFs) and guanine nucleotide dissociation inhibitors (GDIs). Crystallographic studies reveal that the covalent binding of DC-Rhoin to the Cys107 residue stabilizes and captures a novel allosteric pocket. Moreover, the derivative compound DC-Rhoin04 inhibits the migration and invasion of cancer cells, through targeting this allosteric pocket of RhoA. The study reveals a novel allosteric regulatory site within the Rho family, which can be exploited for anti-metastasis drug development, and also provides a novel strategy for inhibitor discovery toward "undruggable" protein targets.
PubMed: 32714746
DOI: 10.1002/advs.202000098
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.454 Å)
Structure validation

247947

PDB entries from 2026-01-21

PDB statisticsPDBj update infoContact PDBjnumon